Table 2.
The prevalence of metabolic syndrome components based on modified WHO criteria in NMOSD and control groups
| Metabolic syndrome component | NMOSD N = 56 |
Control N = 100 |
Un-adjusted p-value |
|---|---|---|---|
| Hypertension (≥140/90 mmHg) | 3 (5.4%) | 2 (2.0%) | 0.35a |
| Dyslipidemia (triglycerides ≥150 mg/dl or HDL cholesterol < 40 mg/dl) | 30 (53.6%) | 52 (52.0%) | 0.87 |
| Hyperglycemia (Fasting glucose ≥110 mg/dl) | 0 (0.0%) | 4 (4.0%) | 0.29a |
| Hyperinsulinemia (forth Quartile) | 27 (48.2%) | 26 (26.0%) | 0.005 |
| waist girth ≥94 cm | 11 (19.6%) | 16 (16.0%) | 0.56 |
| ISQUICKI | 0.32 ± 0.04 | 0.35 ± 0.02 | 0.0001 |
aFisher exact test